Sputum cell‐free <scp>DNA</scp> for detection of alterations of multiple driver genes in lung adenocarcinoma-Reference-Cited by-同舟云学术

Sputum cell‐free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma

Published:2022-09-14 Issue:2 Volume:131 Page:110-116
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Wang Zheng¹,Li Lin²,Wang Yifei¹,Li Xiaoguang³,Xu Yan⁴,Wang Mengzhao⁴,Liang Li⁵,Wu Xiaonan²,Tang Min²,Li Yuanming³,He Shurong¹,Du Jun¹,He Lei¹,Sun Mingjun¹,Yang Li¹,Di Jing¹,Gai Fei⁶,Liu Dongge¹^ORCID

Affiliation:

1. Department of Pathology, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Science Beijing People’s Republic of China

2. Department of Oncology, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Science Beijing People’s Republic of China

3. Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Science Beijing People’s Republic of China

4. Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital Chinese Academy of Medical Sciences, Peking Union Medical College Beijing People’s Republic of China

5. Department of Cancer Chemotherapy and Radiation Sickness Peking University Third Hospital Beijing People’s Republic of China

6. Amoy Diagnostics Co, Ltd, Xiamen People’s Republic of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22644

Reference34 articles.

1. Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer

2. Molecular diagnostics and targeted therapies in non–small cell lung cancer (NSCLC): an update;Jonna S;Discov Med.,2019

3. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

4. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

5. Molecular testing in lung cancer: Fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients;Cancer Medicine;2024-09